BMS-986406

N/A

Report date: 2025/05/09 16:49:31

Base Information

Drug NameBMS-986406
Drug Alias NameBMS-986406ONO-7226
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of Actionanti-Leukocyte immunoglobulin-like receptor subfamily B member 2
TargetsLeukocyte immunoglobulin-like receptor subfamily B member 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesArgentina +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb Srlcompany
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A